<DOC>
	<DOCNO>NCT00812825</DOCNO>
	<brief_summary>The purpose study determine safety , tolerability , pharmacokinetics pharmacodynamics ( drug effect certain target sit activity body ) escalate dose oral PF-04171327 healthy volunteer 14 day ( Part 1 ) . Part 2 evaluate pharmacokinetics single 10 mg dose PF-04171327 tablet healthy volunteer .</brief_summary>
	<brief_title>A Phase 1 Multiple-Dose Escalation Single Dose ( Tablet ) Study PF-04171327 Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Healthy male 18 55 year , inclusive . Healthy female 18 44 year , inclusive . Evidence history clinically significant disease ; Postmenopausal woman ; History intolerance significant adverse effect glucocorticoid . therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Safety Tolerability Pharmacokinetics/pharmacodynamics</keyword>
</DOC>